Keywords: medarex, acquire, housten, biotechnology, company, develops, monoclonal

Medarex To Acquire Housten Biotechnology

Article | 16 December 1996

- Medarex is to acquire Housten Biotechnology, a US company which develops monoclonal antibodies and other biopharmaceutical products for glaucoma and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in